Terns Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 8.14 M | $45.11 M | 30.83% | 10.46% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 7.56 M | $41.90 M | 0.00% | 9.72% |
| VIVO CAPITAL, LLC | 02/13/2025 | 6.90 M | $38.20 M | 0.00% | 8.86% |
| BLACKROCK, INC. | 02/07/2025 | 5.74 M | $31.82 M | 22.23% | 7.38% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 5.58 M | $30.89 M | 0.00% | 7.17% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 4.75 M | $26.32 M | 44.43% | 6.11% |
| VANGUARD GROUP INC | 02/11/2025 | 3.87 M | $21.44 M | 15.28% | 4.97% |
| MORGAN STANLEY | 02/14/2025 | 3.35 M | $18.55 M | 327.60% | 4.30% |
| CITADEL ADVISORS LLC | 02/14/2025 | 3.27 M | $18.10 M | -11.04% | 4.20% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 2.63 M | $14.59 M | 30.59% | 3.38% |
| CANDRIAM S.C.A. | 02/07/2025 | 2.15 M | $11.93 M | 100.00% | 2.77% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 2.02 M | $11.19 M | 49.83% | 2.60% |
| 02/14/2025 | 1.97 M | $10.92 M | 100.00% | 2.53% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.66 M | $9.21 M | -20.55% | 2.14% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.61 M | $8.92 M | 2.01% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.52 M | $8.40 M | 25.59% | 1.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.50 M | $8.34 M | 1.94% | 1.93% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.30 M | $7.22 M | 107.02% | 1.67% |
| STATE STREET CORP | 02/14/2025 | 1.29 M | $7.13 M | 15.22% | 1.65% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.25 M | $6.94 M | -53.76% | 1.61% |
| VR ADVISER, LLC | 02/14/2025 | 1.08 M | $5.97 M | -68.41% | 1.38% |
| BELLEVUE GROUP AG | 02/14/2025 | 1.06 M | $5.88 M | 1.88% | 1.36% |
| NORGES BANK | 02/12/2025 | 849.39 K | $4.71 M | 100.00% | 1.09% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 829.11 K | $4.59 M | 51.92% | 1.07% |
| MARSHALL WACE, LLP | 02/13/2025 | 803.34 K | $4.45 M | 666.85% | 1.03% |
| 02/14/2025 | 752.00 K | $4.17 M | 100.00% | 0.97% | |
| BARCLAYS PLC | 02/13/2025 | 704.37 K | $3.90 M | 642.21% | 0.91% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 628.40 K | $3.48 M | -15.62% | 0.81% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 623.13 K | $3.45 M | 29.96% | 0.80% |
| NORTHERN TRUST CORP | 02/14/2025 | 591.17 K | $3.28 M | 27.44% | 0.76% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 475.00 K | $2.63 M | 43.94% | 0.61% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 450.00 K | $2.49 M | 50.00% | 0.58% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 447.50 K | $2.48 M | -8.11% | 0.58% |
| UBS GROUP AG | 02/14/2025 | 401.66 K | $2.23 M | 478.77% | 0.52% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 398.38 K | $2.21 M | -26.61% | 0.51% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 362.36 K | $2.01 M | 48.16% | 0.47% |
| SALEM INVESTMENT COUNSELORS INC | 01/13/2025 | 346.73 K | $1.92 M | -7.93% | 0.45% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 343.05 K | $1.90 M | -18.10% | 0.44% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 314.39 K | $1.74 M | -31.20% | 0.40% |
| WOODLINE PARTNERS LP | 02/14/2025 | 311.61 K | $1.73 M | 3.45% | 0.40% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 308.49 K | $1.71 M | 0.00% | 0.40% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 253.25 K | $1.40 M | -16.67% | 0.33% |
| LPL FINANCIAL LLC | 02/11/2025 | 252.33 K | $1.40 M | 397.19% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 249.90 K | $1.38 M | 0.32% | 0.32% |
| J. GOLDMAN & CO LP | 02/14/2025 | 235.83 K | $1.31 M | 15.64% | 0.30% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 224.27 K | $1.24 M | 100.00% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 222.51 K | $1.23 M | 0.20% | 0.29% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 206.45 K | $1.14 M | 33.44% | 0.27% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 202.35 K | $1.12 M | 0.00% | 0.26% |
| 02/26/2025 | 200.00 K | $1.11 M | 100.00% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Terns Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 175 institutional investors and hedge funds held shares of Terns Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Penserra Capital Management LLC: 0
CWM, LLC: 0
Capital Advisors, Ltd. LLC: 0
Larson Financial Group LLC: 0
GAMMA Investing LLC: 0
Bleakley Financial Group, LLC: 0
110.67% of Terns Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 81.99 M shares in the last 24 months. This purchase volume represents approximately $286.96 M in transactions.